Seventh Sense Biosystems, Inc.

Description

Howard is Chief Scientific Officer at Seventh Sense Biosystems. Dr. Bernstein has over 20 years of experience in microparticle/nanoparticle technology and drug development. He has been involved in the development of eight different nanoparticulate and microparticulate products including Nutropin Depot, which was the first sustained release product to be approved by the FDA. Before joining Seventh Sense, Dr. Bernstein was Executive Vice President of Research and Development at Acusphere, Inc. and prior to that, he was Vice President of Pharmaceutical Development at Alkermes.

Companies nearby